日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Prevalence of HER2-low status and outcomes in early-stage HER2-negative breast cancer

HER2低表达状态的患病率及早期HER2阴性乳腺癌的预后

Singareeka Raghavendra, Akshara; Liu, Diane D; Pasyar, Sarah; Damodaran, Senthil; Shen, Yu; Mouabbi, Jason A; Barcenas, Carlos H; Tripathy, Debu

Prevalence and Outcomes of HER2-Low Versus HER2-0 Status in Patients with Metastatic Breast Cancer

转移性乳腺癌患者中 HER2 低表达与 HER2 零表达状态的患病率和预后

Singareeka Raghavendra, Akshara; Liu, Diane D; Damodaran, Senthil; Pasyar, Sarah; Shen, Yu; Mouabbi, Jason A; Barcenas, Carlos H; Hunt, Kelly K; Tripathy, Debu

Clinical Characteristics and Survival Outcomes of Metastatic Invasive Lobular and Ductal Carcinoma

转移性浸润性小叶癌和导管癌的临床特征和生存结局

Raghavendra, Akshara S; Bassett, Roland Jr; Damodaran, Senthil; Barcenas, Carlos H; Mouabbi, Jason A; Layman, Rachel; Tripathy, Debu

Characteristics of real-world NATALEE- and monarchE-eligible populations with HR+/HER2- early breast cancer: a United States Electronic Health Records database analysis

真实世界中符合NATALEE和MonarchE入组条件的HR+/HER2-早期乳腺癌患者人群特征:一项基于美国电子健康记录数据库的分析

Tarantino, P; Rugo, H S; Curigliano, G; O'Shaughnessy, J A; Janni, W; Jhaveri, K; Mouabbi, J; Brufsky, A; Hamilton, E; O'Regan, R; Santarsiero, L; Akdere, M; Ye, F; Scotchmer, A; Graff, S L

Incidence and risk factors for pneumonitis due to trastuzumab Deruxtecan in metastatic breast cancer: a retrospective cohort study

转移性乳腺癌患者接受曲妥珠单抗德鲁替康治疗后发生肺炎的发生率和危险因素:一项回顾性队列研究

Azhar, Maria; Soto, Felipe; Su, Amber; Gonzalez, Norma Alicia Vazquez; Medina, Kevin Bernal; Madrigal, Alejandro Lizarraga; Duran, Cesar Chavez; Reyna, Carlos Ignacio Rodriguez; Chan, Colin; Shroff, Girish S; Bassett, Roland L; Pasyar, Sarah; Zhang, David; Shannon, Vickie R; Altan, Mehmet; Mitchell, Melissa P; Meric-Bernstam, Funda; Mouabbi, Jason; Murthy, Rashmi K; Faiz, Saadia A; Bashoura, Lara; Lim, Bora; Sheshadri, Ajay

Impact of concurrent lobular carcinoma in situ on recurrence outcomes in patients with classic and pleomorphic invasive lobular carcinoma of the breast

并发小叶原位癌对经典型和多形性浸润性乳腺小叶癌患者复发结局的影响

Kaur, Mandeep; Quirarte, Astrid; Vertido, Anna; Torosian, Taron; Li, Thomas M; Mouabbi, Jason A; Mukhtar, Rita A

IMG-36. AI-guided retrospective imaging analysis of treatment response to targeted therapy in BRAF V600K metastatic melanoma

IMG-36. AI引导的BRAF V600K转移性黑色素瘤靶向治疗反应的回顾性影像分析

Mărginean, Cristina Oana; Mărginean, Claudiu; Chinceşan, Mihaela; Mărginean, Maria Oana; Meliţ, Lorena Elena; Săsăran, Vlăduţ; Mărginean, Cristian Dan; Rukundo, Beatrice; Kropp, Samantha; Tenhoeve, Sam; Zhao, Yuxin; Chen, Ann; Mendez, Joe; Malani, Rachna; Bang, Charmin; Chartrand, Gabriel; Pawlowski, Sophie; Emiliani, Ramon; Markel, Daniel; Bahig, Houda; Samak, Alexandre; Rajakesari, Selvan; Lavoie, Jérémi; Ducharme, Simon; Roberge, David; Rothschild, Harriet; Jankowitz, Rachel; Shatsky, Rebecca; Mouabbi, Jason; Levine, Julia; Jo Chien, Alliance A; Tur-Sinai, A; Bentur, N; Urban, D; Horta, Erika; Zhou, Yueren; Poisson, Laila M; Griffith, Brent; Stone, Michael; Snyder, James; Walbert, Tobias; Patel, Jay; Beers, Andrew; Chang, Ken; Brown, James; Hoebel, Katharina; Rosen, Bruce; Huang, Raymond; Brastianos, Priscilla; Gerstner, Elizabeth; Kalpathy-Cramer, Jayashree; Chatterjee, Ranee; Erban, John; Fuss, Paul; Vickery, Ellen; LeBlanc, Erin; Sheehan, Patricia; Dolor, Rowena; Johnson, Karen; Kashyap, Sangeeta; Lewis, Michael; Nelson, Jason; Pittas, Anastassios; Martin, Allison; Bell, Robert; Yuan, Ming; Harris, Lauren; Arnold, Antje; Poore, Brad; Asnaghi, Laura; Raabe, Eric; Eberhart, Charles; Chiesa, S; Sabatino, G; Gaudino, S; La Rocca, G; Mazzarella, C; Beghella Bartoli, F; Colosimo, C; Valentini, V; Olivi, A; Balducci, M; Williams, Angela; Dunbar, Tasneem; Carter, Thomas; Betts, Tanya; Megias, Daniel; Vinayan, Anup; Fogh, Shannon; Hoffer, Naomi; Macaire, Greta; Brie, Melissa; Mishra, Kavita; Langley, Blake; Figuracion, Karl Cristie; Chang, Susan; Ribeiro, Anatevka; Chang, Peter; Kong, Xiao-Tang

Efficacy of Single-Agent Chemotherapy in Endocrine Therapy-Refractory Metastatic Invasive Lobular Carcinoma

单药化疗治疗内分泌治疗难治性转移性浸润性小叶癌的疗效

Mouabbi, Jason A; Qaio, Wei; Shen, Yu; Raghavendra, Akshara Singareeka; Tripathy, Debasish; Layman, Rachel M

Survival Outcomes in Patients With Hormone Receptor-Positive Metastatic Breast Cancer With Low or No ERBB2 Expression Treated With Targeted Therapies Plus Endocrine Therapy

接受靶向治疗联合内分泌治疗的激素受体阳性转移性乳腺癌且ERBB2表达低或无表达患者的生存结局

Mouabbi, Jason A; Singareeka Raghavendra, Akshara; Bassett, Roland L Jr; Hassan, Amy; Tripathy, Debasish; Layman, Rachel M

Absence of lobular carcinoma in situ is a poor prognostic marker in invasive lobular carcinoma

小叶原位癌的缺失是浸润性小叶癌预后不良的标志。

Mouabbi, Jason A; Raghavendra, Akshara Singareeka; Bassett, Roland L Jr; Christgen, Matthias; Middleton, Lavinia; Teshome, Mediget; Nasrazadani, Azadeh; Hortobagyi, Gabriel; Hassan, Amy; Tripathy, Debasish; Layman, Rachel M